Currently, AFP and carbohydrate antigen 19-9 are considered the ideal serum tumor markers for HCC and intrahepatic cholangiocarcinoma, yet they are generally deemed unsatisfactory in diagnostic sensitivity or specificity [104]. Here, AFP is linked to hepatocellular carcinoma.